摘要 |
Disclosed are substituted imidazo[1,2-a]pyridines, imidazo[1,2-a]pyrazines, imidazo[1,2-c]pyrimidines and imidazo[1,2-d]triazines compounds of the formula: (1.0) Also disclosed are methods for treating JNK1 and ERK mediated diseases using the compounds of formula 1.0. |
申请人 |
SCHERING CORPORATION;REDDY, PANDURANGA, ADULLA, P.;SIDDIQUI, ARSHAD, M.;TADIKONDA, PRAVEEN, K.;MANSOOR, UMAR, FARUK;SHIPPS, GERALD, W., JR.;BELANGER, DAVID, B.;ZHAO, LIANYUN |
发明人 |
REDDY, PANDURANGA, ADULLA, P.;SIDDIQUI, ARSHAD, M.;TADIKONDA, PRAVEEN, K.;MANSOOR, UMAR, FARUK;SHIPPS, GERALD, W., JR.;BELANGER, DAVID, B.;ZHAO, LIANYUN |